Axenoll 3D Printing Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $8.26M

  • Investors
  • 1

Axenoll 3D Printing General Information

Description

Developer of 3D printing biomaterials machine intended for use in the medical and biotechnological sectors. The company specializes in the global licensing rights for cellular and molecular 3D bioprinting in the context of clean room research and development, production, and marketing based on the patented expertise of 3D mass customization, enabling customers' research and development consulting and OEM production to meet better standards.

Contact Information

Website
www.axenoll.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Otto-Schott-Straße 15
  • 07745 Jena
  • Germany
+49 03641
Primary Industry
Other Commercial Services
Vertical(s)
Corporate Office
  • Otto-Schott-Straße 15
  • 07745 Jena
  • Germany
+49 03641

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axenoll 3D Printing Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 29-Jul-2021 $8.26M Completed Generating Revenue
To view Axenoll 3D Printing’s complete valuation and funding history, request access »

Axenoll 3D Printing Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
Ordinary Shares
Ordinary Shares 1,472,100 $2.72 $2.72 1x $2.72 11.39%
To view Axenoll 3D Printing’s complete cap table history, request access »

Axenoll 3D Printing Patents

Axenoll 3D Printing Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4201439-A1 A three-dimensional biocompatible matrix and its uses in wound management Pending 23-Dec-2021
EP-4452349-A1 A three-dimensional biocompatible matrix and its uses in wound management Pending 23-Dec-2021
US-20250058025-A1 A three-dimensional biocompatible matrix and its uses in wound management Pending 23-Dec-2021
WO-2023118589-A1 A three-dimensional biocompatible matrix and its uses in wound management Inactive 23-Dec-2021
JP-2024546315-A Three-dimensional biocompatible matrices and their use in wound management - patents.com Pending 23-Dec-2021 A61L27/60
To view Axenoll 3D Printing’s complete patent history, request access »

Axenoll 3D Printing Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Xlife Sciences Venture Capital Minority
To view Axenoll 3D Printing’s complete investors history, request access »

Axenoll 3D Printing FAQs

  • When was Axenoll 3D Printing founded?

    Axenoll 3D Printing was founded in 2014.

  • Where is Axenoll 3D Printing headquartered?

    Axenoll 3D Printing is headquartered in Jena, Germany.

  • What industry is Axenoll 3D Printing in?

    Axenoll 3D Printing’s primary industry is Other Commercial Services.

  • Is Axenoll 3D Printing a private or public company?

    Axenoll 3D Printing is a Private company.

  • What is the current valuation of Axenoll 3D Printing?

    The current valuation of Axenoll 3D Printing is .

  • What is Axenoll 3D Printing’s current revenue?

    The current revenue for Axenoll 3D Printing is .

  • How much funding has Axenoll 3D Printing raised over time?

    Axenoll 3D Printing has raised $8.26M.

  • Who are Axenoll 3D Printing’s investors?

    Xlife Sciences has invested in Axenoll 3D Printing.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process